Biologics share of total drug costs in Canada by public drug plan 2017/2018

Biologic share of total drug costs in select Canadian public drug plans in 2017/2018

by Matej Mikulic, last edited Sep 11, 2019
Biologics share of total drug costs in Canada by public drug plan 2017/2018 In fiscal year 2017/2018, the share of biologics of total drug cost in Nova Scotia's public drug plan amounted to 24.6 percent. This statistic depicts the biologic share of total drug costs in selected Canadian public drug plans in FY 2017/2018.
Show more

Biologic share of total drug costs in select Canadian public drug plans in 2017/2018

You need to log in to download this statistic
Register for free
Already a member?
Log in
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "Canadian pharmaceutical industry"
  • Global positioning
The most important statistics
  • Key figures
  • Regional comparison
  • Generics
  • Products and prices
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.